查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
醫療事務的評價(美國)- 潰瘍性大腸炎
市場調查報告書
商品編碼
1769047

醫療事務的評價(美國)- 潰瘍性大腸炎

Medical Affairs Reputations (US) - Ulcerative Colitis
出版日期: | 出版商: FirstWord Group | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

本報告是基於對美國胃腸病學家的調查，對支持潰瘍性結腸炎藥物的醫療事務團隊進行了深入分析。報告探討了醫生與醫療事務團隊互動的頻率和性質、醫生對當前支持的滿意度、首選的溝通管道以及影響參與度的關鍵因素。報告還重點介紹了醫療事務團隊的優勢和麵臨的課題，並就如何優化服務以更好地滿足醫生需求和提升競爭優勢提供了見解。

關鍵問題解答

  • 1.醫師與醫療事務團隊的互動頻率如何？這種頻率是增加還是減少？
  • 2.醫師目前如何使用醫療事務團隊提供的服務？
  • 3.醫療事務支援的哪些面向對醫師最重要？他們對所提供的支援有多滿意？
  • 4.醫師希望與醫學事務團隊進行哪種類型的互動？他們希望這種互動的頻率是多少？
  • 5.醫學事務團隊在多大程度上滿足了醫師的需求？
  • 6.對於某個品牌而言，醫學事務團隊的表現是低於還是高於預期？
  • 7.未來如何改善醫學事務服務，以便更好地滿足醫師的需求？
  • 8.競爭對手的醫學事務團隊在哪些方面最薄弱，哪些方面最強？

領導品牌

  • Remicade
  • Humira
  • Simponi
  • entibio
  • Xeljanz
  • Stelara
  • zeposhia
  • rinbokku
  • omubo
  • skyRidge
  • toremufia

研究方法

FirstView 報告是基於對 LiMATM 選定醫生進行的定量調查而得出。 LiMATM 是全球最大的醫生名錄，擁有超過 300 萬名經過驗證的醫生。每位醫生均根據嚴格的篩選標準精心挑選，以確保收集到的見解具有相關性、可靠性，並反映頂尖醫療專業人士的真實想法和經驗。調查結果以易於理解的圖表形式呈現，方便您快速理解和分析數據。憑藉 LiMATM 的廣泛覆蓋範圍和準確性，FirstView 報告可提供無與倫比的數據驅動洞察，指導您的策略規劃，並幫助您在快速發展的醫療保健領域保持領先地位。

我們的報告有何獨特之處？

FirstWord Reports 是值得信賴的行業領導者，專注於製藥業，為生物製藥專業人士和決策者提供深入可行的洞察。我們深厚的行業知識使我們能夠為您提供相關且有價值的洞察，幫助您掌握新興趨勢，有效應對複雜課題。我們的報告以廣泛的研究以及來自頂尖專家和關鍵意見領袖 (KOL) 的獨立、公正的見解為後盾，為您提供所需的準確性和可靠性。獨家訪談和數據，以及持續的市場監測，讓您全面了解市場動態。我們的報告涵蓋 40 多個活躍的疾病領域，包括 KOL 洞察和定量醫生調查在內的醫生情報，以及行業專家對醫療事務、數位健康、銷售與行銷、市場准入和其他領域問題的看法，使您能夠做出更明智的數據驅動決策，並在快速變化的行業中保持競爭力。

簡介目錄

This report provides a detailed analysis of Medical Affairs teams supporting therapies for ulcerative colitis, based on a survey of US gastroenterologists. It explores the frequency and nature of physician interactions with Medical Affairs, physicians' satisfaction with current support, preferred communication channels, and key factors that influence engagement. The report also highlights areas where Medical Affairs teams excel or face challenges, offering insights into how services can be optimized to better meet physician needs and improve competitive positioning.

Key Questions Answered:

  • 1. How frequently do physicians interact with Medical Affairs teams, and is the frequency of this interaction increasing or decreasing?
  • 2. In what ways do physicians currently use the services provided by Medical Affairs teams?
  • 3. What aspects of Medical Affairs support are most important to physicians and how satisfied are they with the support provided?
  • 4. What are the preferred mediums for interactions between physicians and Medical Affairs teams and what is the preferred frequency of these interactions?
  • 5. How successful are Medical Affairs teams at meeting physician needs?
  • 6. Are Medical Affairs teams falling short or exceeding goals with any particular brands?
  • 7. How can Medical Affairs services be improved to better meet the needs of physicians in the future?
  • 8. In what areas are your competitors' Medical Affairs teams weakest and strongest?

Key Brands:

  • Remicade
  • Humira
  • Simponi
  • Entyvio
  • Xeljanz
  • Stelara
  • Zeposia
  • Rinvoq
  • Omvoh
  • Skyrizi
  • Tremfya

Methodology:

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.